UG Healthcare Corporation Limited provided earnings guidance for the six months ended 31 December 2022. For the period, the group is expected to report a net loss for HY23. The expected net loss is mainly due to higher operating expenses at the upstream manufacturing of disposable examination gloves amidst declining average selling prices for nitrile and latex disposable examination gloves, and lower sales volume as customers prefer to hold lower inventories.
UG Healthcare Corporation Limited
Equities
8K7
SGXE48766716
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 SGD | -1.79% | 0.00% | -34.13% |
Feb. 16 | UG Healthcare Grants 2.8 Million Share Options | MT |
Feb. 14 | UG Healthcare's Fiscal H1 Loss Widens as Revenue Drops on Lower Latex Glove Prices; Shares Fall 5% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.13% | 50.36M | |
+11.84% | 27.79B | |
-32.98% | 2.98B | |
-15.97% | 2.52B | |
+11.90% | 2.34B | |
-1.11% | 1.91B | |
-13.37% | 1.83B | |
-7.78% | 1.39B | |
-0.38% | 1.27B | |
+4.01% | 1.13B |
- Stock Market
- Equities
- 8K7 Stock
- News UG Healthcare Corporation Limited
- UG Healthcare Corporation Limited Provides Earnings Guidance for the Six Months Ended 31 December 2022